Inspira Technologies, under the ticker symbol IINN on Nasdaq, has made a groundbreaking announcement about promising initial findings in its collaborative research with Ennocure MedTech. This alliance aims to develop an innovative bio-electronic treatment to prevent bloodstream infections, a concern causing over 250,000 annual reports linked to intravenous lines globally. The ex-vivo testing on a…